A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

Clinical trial NCT04129164 · COMPLETED

Trial details

NCT number: NCT04129164
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sjögren's Syndrome

Start date: 2019-12-09
Primary completion: 2022-09-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.